Module

Biomedical entrepreneurship

Intellectual Property Online

Obtaining a patent is a crucial step to safeguard the intellectual property of a novel biomedical intervention and to raise funding for its development. The Intellectual Property program at Paul Janssen Futurelab Leiden provides “learning-by-doing” training to ambitious postgraduate biomedical researchers who wish to further their career and increase their knowledge of intellectual property. The program focuses on the pros and cons of intellectual property and the do’s and don’ts to protect your biomedical invention in a timely manner.

In this five-week online Futurelab course, biomedical professionals are introduced to the world of intellectual property (IP) for novel medical interventions. You will learn the value of a patent (and its limits) for your own biomedical research program, institute, or company. You will learn to identify which inventions can be patented and to determine the basics of your patent strategy worldwide. Topics that will be addressed are: What are the principles of patent law and designers rights? What are the pros and cons of patent protection and when should you start a patenting procedure? In addition, you will learn how to use available public patent databases and identify which aspects are relevant to build a patent portfolio. Finally, we will address freedom to operate, patent enforcement and licensing strategies and we will share with you some trade secrets.

To deepen  your acquired skills, realistic case studies based on real-world biomedical inventions are included in exercises to illustrate the complexity and dynamics involved in patents in this field.

For your assistance, a Futurelab Patent Calculator has been developed, to support you in estimating the costs of obtaining and maintaining patents. The POC tool allows you to calculate multiple patent costs for patents in one or more countries and is accessible for course participants of the online course Intellectual Property. A simplified version of the Patent Calculator will soon be freely available via the Paul Janssen Futurelab website.

A multifaceted online course

In this online course, a variety of exercises will help you master the POC tool and understand the dynamics of intellectual property in realistic scenarios based on real-world case studies. In addition, the online course uses a wide variety of teaching methods including animations, tutorials, articles, interviews with industry, legal experts, and authorities, Futurelab talks, self-assessments, tools, quizzes, assignments, online discussions with fellow course participants, and feedback from Futurelab experts.

Study time

You will be expected to spend approximately 5 hours per week for five consecutive weeks.

Online exam

Your understanding of the course material will be assessed by an online exam. You will need access to a laptop with webcam, a stable internet connection, a clean desk, and a private room. Participants will be monitored by a professional invigilator via webcam during the exam. After passing the exam, you will obtain a Paul Janssen Futurelab certificate and will be eligible to apply for the on-campus IP course.

Learning outcomes

Upon completion of this online course, you will have a clear understanding of the pros and cons of intellectual property and the do’s and don’ts to protect your biomedical invention in a timely manner. Specifically, you will be able to:

  1. perform patent searches in the public patent data bases, including the analysis of a patent’s legal status;
  2. identify different patenting routes, including cost estimates, and develop a cost-effective patenting strategy;
  3. design a patent portfolio, for example with a specialized patent attorney;
  4. how to conduct patent enforcement procedures;
  5. plan the commercialization of patents, including licensing as a tool for exploiting intellectual property.

Requirements

  • A master’s degree in any subject related to biomedical science;
  • Several years of relevant working experience;
  • No prior knowledge or experience with intellectual property is required for this course.

We offer a 25% discount to non-profit organizations. Select your option and select your start date:

Clear

Program information

Course length5 weeks

Study load5 hours a week

Your teacher

Kees Recourt

Investment Manager

Biomedical entrepreneurship contributors

Intellectual Property Online

Henk Schuring

VP-Head Rare Nephrology
Sanofi Genzyme

Intellectual Property Online

Sjaak Bot

VP, Head of EMEA Regulatory Affairs
Janssen

Intellectual Property Online

Bernd van der Meulen

Professor of Comparative Food Law
European Institute for Food Law / Renmin University of China Law School

Intellectual Property Online

Frank Landolt

V.P. intellectual property and legal
Ablynx N.V.

Intellectual Property Online

Erik Niks

Neurologist - Pediatric neurologist
Leiden University Medical Center

Intellectual Property Online

Piet Hinoul

Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon

Intellectual Property Online

Ad Sitsen

Owner
ClinPharMed Consultancy for Drug Development

Intellectual Property Online

Wim Parys

Head of R&D Global Public Health
Janssen Pharmaceutica

Intellectual Property Online

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC

Intellectual Property Online

Maurits Westerik

Senior Counsel
Bird & Bird

Intellectual Property Online

Andrea Kamage

Patent Group Leader
Johnson & Johnson

Intellectual Property Online

Bart Swinkels

Partner
NLO

Intellectual Property Online

Karin Verzijden

Food and Pharma Lawyer
Axon Lawyers

Intellectual Property Online

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development
Eagle Pharma Consult

Intellectual Property Online

Kees Recourt

Investment Manager
Mibiton Foundation

Intellectual Property Online

Paul Stoffels

Chief scientific officer
Johnson & Johnson

Intellectual Property Online

Tom Huizinga

Head of the Department of Rheumatology
Leiden University Medical Centre

Intellectual Property Online

Marcel Kenter

Director
Paul Janssen Futurelab Leiden

Intellectual Property Online

Koen Andries

VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV

Intellectual Property Online

Andreas Wallnöfer

General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)

Intellectual Property Online

Justin Hay

Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency

Intellectual Property Online

André Elferink

Clinical epidemiologist
Dutch Medicines Evaluation Board

Intellectual Property Online

Rob Zuiker

Senior Clinical Scientist
CHDR

Intellectual Property Online

Barbara J. van Zwieten-Boot

Vice Chair
Medicines Evaluation Board, The Netherlands

Intellectual Property Online

Hans-Georg Eichler

Senior Medical Officer
European Medicines Agency

Intellectual Property Online

Robert Klautz

Thoracic Surgeon
Leiden University Medical Centre

Intellectual Property Online

Matthijs Moerland

Research Director Translational Biomarkers
CHDR

Intellectual Property Online

Joris Rotmans, MD, PhD

internist-nephrologist
LUMC

Intellectual Property Online

Janneke Meulenberg

CEO
Arthrogen

Intellectual Property Online

Inge de Lepeleire

Director Translational Pharmacology
MSD Europe

Intellectual Property Online

Koos Burggraaf

Research Director CVS & Metabolism
CHDR

Intellectual Property Online

Johan Garssen

Director Immunology Platform
Danone/Nutricia Research

Intellectual Property Online

Ingrid de Visser

Senior Clinical Scientist
CHDR

Intellectual Property Online

Rick Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic

Intellectual Property Online

Geert Jan Groeneveld

Research Director CNS
CHDR

Intellectual Property Online

Oliver Bisazza

Director Regulatory Policy
Medtronic

Intellectual Property Online

Saco de Visser

Head of Education and Clinical Pharmacologist
Paul Janssen Futurelab Leiden

Intellectual Property Online

Adam Cohen

CEO and clinical pharmacologist
Centre for Human Drug Research

Intellectual Property Online

Richard Shull

Head of Deal Structuring and Trading Fundamentals
Shell

Intellectual Property Online

Pierre Peeters

Former site head early stage development
Organon

Stay updated about this course